Glial Fibrillary Acidic Protein (GFAP) Peptide
-
- Target See all GFAP products
- GFAP (Glial Fibrillary Acidic Protein (GFAP))
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Purpose
- GFAP Negative Control Antigen
- Sequence
- (C)RHLGTIPRLS LSR, correspond ing to amino acid residues 27-39 of rat Glial fibrillary acidic protein (Accession P47819).
- Characteristics
- Synthetic peptide, A Blocking peptide for Anti-GFAP Antibody (ABIN7043217, ABIN7044273 and ABIN7044274)). Intended to be used as a negative control.
- Purity
- >70 %
-
-
- Application Notes
- Antigen Preadsorption Control: 1 μg peptide per 1 μg antibody.
- Comment
-
Confirmed by amino acid analysis and mass spectrometry.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- 100 μL double distilled water (DDW).
- Concentration
- 0.4 mg/mL
- Storage
- RT,-20 °C
- Storage Comment
- Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.
-
- Target
- GFAP (Glial Fibrillary Acidic Protein (GFAP))
- Synonyms
- GFAP Peptide, AI836096 Peptide, cb345 Peptide, etID36982.3 Peptide, gfapl Peptide, wu:fb34h11 Peptide, wu:fk42c12 Peptide, xx:af506734 Peptide, zgc:110485 Peptide, glial fibrillary acidic protein Peptide, GFAP Peptide, LOC100136168 Peptide, gfap Peptide, Gfap Peptide
- Gene ID
- 24387
- NCBI Accession
- NM_002055
- UniProt
- P47819
-